Metropolitan Life Insurance CO Angion Biomedica Corp. Transaction History

Metropolitan Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.35 - $9.95 $17,439 - $73,838	-7,421 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$9.31 - $13.25 $69,089 - $98,328	7,421 New	7,421 $72,000
Q3 2021 Mar 30, 2023	BUY	$9.31 - $13.25 $69,089 - $98,328	7,421 New	7,421 $72,000
Q3 2021 Nov 15, 2021	BUY	$9.31 - $13.25 $69,089 - $98,328	7,421 New	7,421 $73,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.